A randomized trial of amantadine and interferon versus interferon alone as initial treatment for chronic hepatitis C.

Mangia, A; Minerva, N; Annese, M; Leandro, G; Villani, M R; Santoro, R; Carretta, V; Bacca, D; Giangaspero, A; Bisceglia, M; Ventrella, F; Dell'Erba, G; Andriulli, A

Mangia, A; Minerva, N; Annese, M; Leandro, G; Villani, M R; Santoro, R; Carretta, V; Bacca, D; Giangaspero, A; Bisceglia, M; Ventrella, F; Dell'Erba, G; Andriulli, A.

Affiliation

Mangia A; Division of Gastroenterology and Department of Human Pathology, Ospedale "Casa Sollievo della Sofferenza," IRCCS, San Giovanni Rotondo, Ospedale Canosa, Italy. a.mangia@tin.it

Hepatology ; 33(4): 989-93, 2001 Apr.

Article in En | MEDLINE | ID: mdl-11283865

Subject(s)

Amantadine/therapeutic use; Antiviral Agents/therapeutic use; Hepatitis C, Chronic/drug therapy; Interferons/therapeutic use; Adult; Aged; Alanine Transaminase/blood; Amantadine/adverse effects; Antiviral Agents/adverse effects; Drug Therapy, Combination; Female; Genotype; Hepacivirus/genetics; Hepatitis C, Chronic/blood; Hepatitis C, Chronic/virology; Humans; Interferons/adverse effects; Male; Middle Aged; Predictive Value of Tests; RNA, Viral/analysis; Safety

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Amantadine / Interferons / Hepatitis C, Chronic Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Hepatology Year: 2001 Document type: Article Affiliation country: Italy Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links